ALTEROME

Serial Number 97397313
602

Registration Progress

Application Filed
May 5, 2022
Under Examination
May 30, 2023
Approved for Publication
Apr 4, 2023
Published for Opposition
Apr 4, 2023
Registered

Trademark Image

ALTEROME

Basic Information

Serial Number
97397313
Filing Date
May 5, 2022
Published for Opposition
April 4, 2023
Abandonment Date
December 20, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jan 6, 2025
Classes
042

Rights Holder

Alterome Therapeutics, Inc.

03
Address
13480 Evening Creek Dr. North
Suite 450
San Diego, CA 92128

Ownership History

Alterome Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Alterome Therapeutics, Inc.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Kari Moyer-Henry

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description Documents
Jan 6, 2025 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jan 6, 2025 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Sep 19, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 19, 2024 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Sep 19, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jul 6, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 6, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 6, 2024 IUAF S USE AMENDMENT FILED Loading...
Jun 4, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 4, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 4, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 31, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 31, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 31, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 28, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 28, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 28, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 30, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 4, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 4, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 1, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 23, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 10, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 9, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical drug development services; Pharmaceutical products development
First Use Anywhere: May 1, 2024
First Use in Commerce: May 1, 2024

Classification

International Classes
042